Skip to main content
SpringerLink
Log in
Book cover

Red Cell Transfusion pp 105–119Cite as

Transfusion Support in Solid-Organ Transplantation

  • Chapter

  • 145 Accesses

Part of the book series: Contemporary Hematology ((CH))

Abstract

Solid-organ transplantation continues to grow as a treatment modality in this country, limited only by the availability of organs. Total transplants in the United States were up 3.6% in 1995 with liver, lung, and kidney accounting for the majority of the increase (see Table 1). Transfusion support remains an integral part of solid-organ transplantation, imparting demands on the transfusion service not only quantitatively in terms of blood product support, but also qualitatively with respect to consultation for increasingly complex clinical issues. Aside from the well-known problems associated with massive transfusion, transplant recipients present unique challenges in terms of requirements for specialized blood components, serologic problems, and immunologic effects of transfusion on both the allograft and the recipient. This chapter explores the laboratory and clinical issues involved in transfusion support of solid-organ transplantation.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bontempo FA, Lewis JH, Van Thiel DH, Spero JA, Ragni MV, Butler P, Israel L, Starzl TE. The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation 1985;39:532–536.

    Article  PubMed  CAS  Google Scholar 

  2. Kang Y, Lewis JH, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE: e-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 1987;66:766–773.

    Article  PubMed  CAS  Google Scholar 

  3. Nicol SL, Shirey RS, Banez-Sese GC, Ness PM. Signifiance of residual plasma from group O additive solution RBC transfusions (abstract). Transfusion 1995;35(Suppl): S247.

    Article  Google Scholar 

  4. Casanueva M, Valdes MD, Ribera MC. Lack of allo-immunization to D antigen in D-negative immunosuppressed liver transplant recipients. Transfusion 1994;34:570–572.

    Article  PubMed  CAS  Google Scholar 

  5. Jain A, Venkataramanan R, Lever J, Warty V, Fung J, Todo S, Starzl T. FK506 and pregnancy in liver transplant patients (letter). Transplantation 1993;56:751.

    Google Scholar 

  6. Ramsey G, Cornell FW, Hahn LF, Larson P, Issitt LB, Starzl TE. Red cell antibody problems in 1000 liver transplants. Transfusion 1989;29:396–399.

    Article  PubMed  CAS  Google Scholar 

  7. Ramsey G, Cornell FW, Hahn LF, Fonzi F, Starzl TE. Incompatible blood transfusions in liver transplant patients with significant red cell alloantibodies. Transplant Proc 1989;21:3531.

    PubMed  CAS  Google Scholar 

  8. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990;12(Suppl):S754–S766.

    Article  PubMed  Google Scholar 

  9. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 1990;12(Suppl): S701–S710.

    Article  PubMed  Google Scholar 

  10. Grundy JE, Super M, Sweny P, Moorhead J, Lui SF, Berry NJ, Fernando ON, Griffiths PD. Symptomatic cyto-megalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 1988;371:132–135.

    Article  Google Scholar 

  11. Preiksaitis JK. Indications for the use of cytomeglovirus seronegative blood products. Transfusion Med Rev 1991;5:1–17.

    Article  CAS  Google Scholar 

  12. Fryd DS, Peterson PK, Ferguson RM, Simmons RL, Balfour HH, Najarian JS: Cytomegalovirus as a risk factor in renal transplantation. Transplantation 1980;30:436–439.

    Article  PubMed  CAS  Google Scholar 

  13. Laske A, Gallino A, Carrel T, Niederhauser U, von Segesser LK, Turina MI: Cytomegalovirus infection and prophylaxis in heart transplantation. Transplant Proc 1993;25:1427–1428.

    PubMed  CAS  Google Scholar 

  14. Grossi P, Minoli L, Percivalle E, Irish W, Vigano M, Gerna G. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Transplantation 1995;59:847–851.

    PubMed  CAS  Google Scholar 

  15. Egan JJ, Barber L, Lomax J, Fox A, Yonan N, Rahman AN, Campbell CS, Deiraniya AK, Carroll KB, Craske J, Turner A, Woodcock AA. Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients. Thorax 1995;50:9–13.

    Article  PubMed  CAS  Google Scholar 

  16. Smyth RL, Scott JP, Borysiewicz LK, Sharpies LD, Stewart S, Wreghitt TG, Gray JJ, Higenbottam TW, Wallwork J. Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. J Infect Dis 1991;164:1045–1050.

    Article  PubMed  CAS  Google Scholar 

  17. Winston DJ, Wirin D, Shaked A, Busuttil RW. Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet 1995;346:69–74.

    Article  PubMed  CAS  Google Scholar 

  18. Rakela J, Wiesner RH, Taswell HF, Hermans PE, Smith TF, Perkins JD, Krom RAF. Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. Transplant Proc 1987;19:2399–2402.

    PubMed  CAS  Google Scholar 

  19. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598–3603.

    PubMed  CAS  Google Scholar 

  20. Burdick JF, Vogelsang GB, Smith WJ, Farmer ER, Bias WB, Kaufmann SH, Horn J, Colombani PM, Pitt HA, Perler BA, Merritt WT, Williams GM, Boitnott JK, Herlong HF. Severe graft-vs host disease in a liver transplant recipient. N Engl J Med 1988;318:689–691.

    Article  PubMed  CAS  Google Scholar 

  21. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, Lynch R, Ferrell L, Wright T. Graft-vs-host disease after liver transplantation in humans: a report of four cases. Hepatology 1991;14:274–281.

    Article  PubMed  CAS  Google Scholar 

  22. Wisecarver JL, Cattral MS, Langnas AN, Shaw BW, Fox IJ, Heffron TG, Rubocki RJ. Transfusion-induced graft-versus-host disease after liver transplantation. Transplantation 1994;58:269–271.

    PubMed  CAS  Google Scholar 

  23. Sola MA, Espana A, Redondo P, Idoate MA, Fernandez AL, Llorens R, Quintanilla E. Transfusion-associated acute graft-versus-host disease in a heart transplant recipient. Br J Dermatol 1995;132:626–630.

    Article  PubMed  CAS  Google Scholar 

  24. Sliman GA, Beschorner WG, Baughman KL, et al. Graft-versus-host-like disease in a heart allograft recipient: a possible autoimmune phenomenon. Transplantation 1988;45:253–256.

    Article  PubMed  CAS  Google Scholar 

  25. Wood H, Higenbottam T, Joysey V, Wallwork J. Graft-versus-host disease after human heart-lung transplantation. International Congress of the Transplantation Society (abstract) 1990;364.

    Google Scholar 

  26. Andany MA, Martinez W, Arnal F, Yebra T, Falcon TG, Lozano IR, Lorenzo D, Alonso A. Transfusion-associated graft-versus-host disease in a renal transplant recipient. Nephrol Dial Transplant 1994;9:196–198.

    Google Scholar 

  27. Andersen CB, Ladefoged SD, Taaning E. Transfusion-associated graft-versus-graft and potential graft-versus-host disease in a renal allotransplanted patient. Hum Pathol 1992;23:831–834.

    Article  PubMed  CAS  Google Scholar 

  28. Deierhoi MH, Sollinger HW, Bozdech MJ, Beizer FO. Lethal graft-vs-host disease in a recipient of a pancreas-spleen transplant. Transplantation 1986;41:544–546.

    Article  PubMed  CAS  Google Scholar 

  29. Anderson KC, Goodnough LT, Sayers M, Pisciotto PT, Kurtz SR, Lane TA, Anderson CS, Silberstein LE. Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood 1991;77:2096–2102.

    PubMed  CAS  Google Scholar 

  30. Opelz G, Sengar DPS, Mickey MR, et al. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5:253–259.

    PubMed  CAS  Google Scholar 

  31. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966;2:662–665.

    Article  PubMed  CAS  Google Scholar 

  32. Horimi T, Terasaki PI, Chia D, Sasaki N. Factors influencing the paradoxical effect of transfusions on kidney transplants. Transplantation 1983;35:320–323.

    Article  PubMed  CAS  Google Scholar 

  33. Colombe BW, Lou CD, Salvatierra O, Jr, Garovoy MR. Two patterns of sensitization demonstrated by recipients of donor-specific transfusion: limitations to control by Imuran. Transplantation 1987;44:509.

    Article  PubMed  CAS  Google Scholar 

  34. Bayle F, Masson D, Zaoui P, Vialtel P, Janbon B, Bensa JC, Cordonnier DJ. Beneficial effect of one HLA haplo-or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients. Transplantation 1995;59:719–723.

    Article  PubMed  CAS  Google Scholar 

  35. Radvany RM, Patel KM. Donor-specific transfusions. Donor-recipient HLA compatibility, recipient HLA haplotype, and antibody production. Transfusion 1988;28:137–141.

    Article  PubMed  CAS  Google Scholar 

  36. Cheigh JS, Suthanthiran M, Fotino M, et al. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. Transplantation 1991;51:378–381.

    Article  PubMed  CAS  Google Scholar 

  37. Lagaaij EL, Hennemann IPH, Ruigrok M, de Haan MW, Persijn GG, Termijtelen A, Hendriks GFJ, Weimar W, Claas FHJ, van Rood JJ. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989;321:701–705.

    Article  PubMed  CAS  Google Scholar 

  38. Ahmed Z, Terasaki PI. Effect of transfusion. In: Terasaki PI, ed. Clinical Transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1991, pp. 305–312.

    Google Scholar 

  39. Fisher M, Chapman JR, Ting A, Morris PJ. Alloimmunization to HLA antigens following transfusion with leukocyte-poor and purified platelet suspensions. Vox Sanguinis 1985;49:331–335.

    Article  PubMed  CAS  Google Scholar 

  40. Flye MW, Burton K, Mohanakumar T, Brennan D, Keller C, Goss JA, Sicard GA, Anderson CB. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995;60:1395–1401.

    Article  PubMed  CAS  Google Scholar 

  41. Bayle F, Masson D, Zaoui P, Janbon B, Bensa JC, Vialtel P. One HLA haplo-identical transfusion in first renal allo-graft recipients: effect on alloimmunisation, acute rejection episodes, and graft survival. Transplant Proc 1995;27:2457–2458.

    PubMed  CAS  Google Scholar 

  42. Lavee J, Kormos RL, Duquesnoy RJ, Zerbe TR, Armitage JM, Vanek M, Hardesty RL, Griffith BP. Influence of panel reactive antibody and positive lymphocytotoxic crossmatch on cardiac transplant survival. J Heart Lung Transplant 1991;10(6):921–929.

    PubMed  CAS  Google Scholar 

  43. Sucui-Foca N, Reed E, Marboe C. The role of anti-HLA antibodies in heart transplantation. Transplantation 1993;51:716–724.

    Article  Google Scholar 

  44. Johnson CP, Munda R, Alexander JW, Balakrishnan K, Blanton M. The effect of donor-specific transfusions on rat heart allograft survival. Transplantation 1984;38:575–578.

    Article  PubMed  CAS  Google Scholar 

  45. Dong E, Stinson EB, Griepp RB, Coulson AS, Shumway NE. Cardiac transplantation following failure of previous cardiac surgery. Surg Forum 1973;24:150–152.

    PubMed  Google Scholar 

  46. Cooper DKC, Boyd ST, Lanza RP, Barnard CN. Factors influencing survival following heart transplantation. Heart Transplant 1983;3:86–91.

    Google Scholar 

  47. Katz MR, Barnhart GR, Goldman MH, Rider S, Hastillo A, Szentpetery S, Wolfgang TC, Hess ML, Mohanakumar T, Lower RR. Pretransplant transfusions in cardiac allograft recipients. Transplantation 1987;43:499–501.

    Article  PubMed  CAS  Google Scholar 

  48. Kerman RH, Van Buren CT, Lewis RM, Frazier OH, Cooley D, Kahan BD. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine. Transplantation 1988;45:333–337.

    Article  PubMed  CAS  Google Scholar 

  49. Keogh A, Baron D, Chang V. The effect of blood pretransfusion on orthotopic cardiac transplantation. Transplant Proc 1987;19:2503.

    PubMed  CAS  Google Scholar 

  50. Opelz G. Factors affecting the outcome of kidney and heart transplants today. 8th Scientific Meeting of the Transplantation Society of Australia and New Zealand, March 1990.

    Google Scholar 

  51. Keenan RJ, Zeevi A. Immunologic consequences of transplantation. Basic Biol Thorac Surg 1995;5:107–120.

    CAS  Google Scholar 

  52. Nelson KA, Albert RK, Davies C, et al. Association of antibody to donor HLA class I antigens with early acute lung rejections in lung transplant recipients. Am J Respir Crit Care Med 1994;149:A1097.

    Google Scholar 

  53. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo TG, Yousem SA, Close JM, Zeevi A, Duquesnoy RJ, Manzetti J, Keenan RJ, Armitage JM, Hardesty RL, Griffith BP. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 1995;110:4–13.

    Article  PubMed  CAS  Google Scholar 

  54. Bird G, Friend P, Donaldson P, O’Grady J, Portmann B, Calne R, Williams R. Hyperacute rejection in liver transplantation: a case report. Transplant Proc 1989;21:3742–3744.

    PubMed  CAS  Google Scholar 

  55. Takaya S, Bronsther O, Iwaki Y, Nakamura K, Abu-Elmagd K, Yagihashi A, Demetris AJ, Kobayashi M, Todo S, Tzakis AG, Fung JJ, Starzl TE. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992;53:400–406.

    Article  PubMed  CAS  Google Scholar 

  56. Lobo PI, Spencer C, Douglas MT, Stevenson WC, Pruett TL. The lack of long-term detrimental effects on liver allografts caused by donor-specific anti-HLA antibodies. Transplantation 1993;55:1063–1066.

    Article  PubMed  CAS  Google Scholar 

  57. Weber T, Marino IR, Kang YG, Esquivel CO, Starzl TE, Duquesnoy RJ. Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation 1989;47:797–801.

    Article  PubMed  CAS  Google Scholar 

  58. Yokoi Y, Yamaguchi A, Kimura H, Nakamura S, Baba S, Amemiya H. Donor-specific transfusion: critical role of class I antigen presenting molecules in rat liver transplantation. Transplant Proc 1995;27:1558–1559.

    PubMed  CAS  Google Scholar 

  59. Rouch DA, Thistlethwaite JR, Lichtor L, Emond JC, Broelsch CE. Effect of massive transfusion during liver transplantation on rejection and infection. Transplant Proc 1988;20:1135–1137.

    PubMed  CAS  Google Scholar 

  60. Palomo JC, Jiminez C, Moreno E, Garcia MA, Bercedo J, Loinaz C, Palma F, Ibanez J, Corral MA. Effects of intraoperative blood transfusion on rejection and survival after orthotopic liver transplantation. Transplant Proc 1995;27:2326–2327.

    PubMed  CAS  Google Scholar 

  61. Starzl TE, Marchioro TL, Holmes JH, Waddell WR. The incidence, cause and significance of immediate and delayed oliguria or anuria after human renal transplantation. Surg Gynecol Obstet 1964;188:819–827.

    Google Scholar 

  62. Demetris AJ, Murase N, Nakamura K, Iwaki Y, Yagihashi A, Valdivia L, Todo S, Iwatsuki S, Takaya S, Fung JJ. Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis 1992;12:51–59.

    Article  PubMed  CAS  Google Scholar 

  63. Cook DJ, Graver B, Terasaki PI. ABO incompatibility in cadaver donor kidney allografts. Transplant Proc 1987;19:4549–4552.

    PubMed  CAS  Google Scholar 

  64. Cooper DKC. Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors. J Heart Transplant 1990;9:376–381.

    PubMed  CAS  Google Scholar 

  65. Alexandre GPJ, Squifflet JP, De Bruyere M, Latinne D, Reding R, Gianello P, Carlier M, Pirson Y. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987;19:4538–4542.

    PubMed  CAS  Google Scholar 

  66. Carvana RJ, Zumbro GL Jr, Hoff RG, Rao RN, Daspit SA. Successful cardiac transplantation across an ABO blood group barrier. Transplantation 1988;46:472–474.

    Article  Google Scholar 

  67. Cooper DKC, Ye Y, Kehoe M, Niekrasz M, Rolf LL Jr, Martin M, Baker J, Kosanke S, Zuhdi N, Worsley G, Romano E. A novel approach to “neutralization” of preformed antibodies: cardiac allotransplantation across the ABO blood group barrier as a paradigm of discordant transplantation. Transplant Proc 1992;24:566–571.

    PubMed  CAS  Google Scholar 

  68. Nelson PW, Helling TS, Shield CF, Becj M, Bryan CF. Current experience with renal transplantation across the ABO barrier. Am J Surg 1992;164:541–544.

    Article  PubMed  CAS  Google Scholar 

  69. Belle SH, Beringer KC, Murphy JB, Detre KM. The Pitt-Unos liver transplant registry. In: Terasaki PI and Cecka JM, eds. Clinical Transplants 1992. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1992, p. 7.

    Google Scholar 

  70. Demetris AJ, Jaffe R, Tzakis A, Ramsey G, Todo S, Belle S, Esquivel C, Shapiro R, Zjako A, Markus B, Morozec E, Van Thiel DH, Sysyn G, Gordon R, Makowka L, Starzl TE. Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers. Transplant Proc 1989;21:2217–2220.

    PubMed  CAS  Google Scholar 

  71. Gugenheim J, Samuel D, Fabiani B, Saliba F, Castaing D, Reynes M, Bismuth H. Rejection of ABO incompatible liver allografts in man. Transplant Proc 1989;21:2223–2224.

    PubMed  CAS  Google Scholar 

  72. Farges O, Kalil AN, Samuel D, Saliba F, Arulnaden JL, Debat P, Bismuth A, Castaing D, Bismuth H. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995;59:1124–1133.

    PubMed  CAS  Google Scholar 

  73. Cacciarelli TV, So SKS, Lim J, Concepcion W, Cox K, Esquivel CO: A reassessment of ABO incompatibility in pediatric liver transplantation. Transplantation 1995;60:757–768.

    Article  PubMed  CAS  Google Scholar 

  74. Mor E, Skerrett D, Manzarbeitia C, Sheiner PA, Schwartz ME, Emre S, Thung SN, Miller CM: Successful use of an enhanced immunosuppressive protocol with plasma-pheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation 1995;59:986–990.

    Article  PubMed  CAS  Google Scholar 

  75. Renard TH, Andrews WS: An approach to ABO-incompatible liver transplantation in children. Transplantation 1992;53:116–121.

    Article  PubMed  CAS  Google Scholar 

  76. Conference of the Consensus on the indications of liver transplantation. Hepatology 1994;20(1 pt 2).

    Google Scholar 

  77. Gordon RD, Iwatsuki S, Esquivel CO, Tzakis A, Todo S, Starzl TE. Liver transplantation across ABO blood groups. Surgery 1986;100:342–348.

    PubMed  CAS  Google Scholar 

  78. Ramsey G. Red cell antibodies arising from solid organ transplants. Transfusion 1991;31:77–86.

    Article  Google Scholar 

  79. Swanson JL, Sastamoinen RM, Steeper TA, Sebring ES. Gm allotyping to determine the origin of red cell antibodies in recipients of solid organ transplants. Vox Sanguinis 1987;52:75–78.

    Article  PubMed  CAS  Google Scholar 

  80. Triulzi DJ, Shirey RS, Ness PM, Klein AS. Immunohematologic complications of ABO unmatched liver transplants. Transfusion 1992;32:829–833.

    Article  PubMed  CAS  Google Scholar 

  81. Orchard J, Young NT, Smith C, Thomas S, Darke C. Severe intravascular haemolysis in a renal transplant recipient due to anti-B of donor origin. Vox Sanguinis 1990;59:172–175.

    Article  PubMed  CAS  Google Scholar 

  82. Magrin GT, Street AM, Williams TJ, Esmore DS. Clinically significant anti-A derived from B lymphocytes after single lung transplantation. Transplantation 1993;56:466–467.

    Article  PubMed  CAS  Google Scholar 

  83. Taaning E, Morling N, Mortensen SA, Pettersson G, Simonsen AC. Hemolytic anemia due to graft-derived anti-B production after lung transplantation. Transplant Proc 1994;26:1739.

    PubMed  CAS  Google Scholar 

  84. Perlman EJ, Shirey RS, Farkosh M, Kickler TS, Ness PM. Immune hemolytic anemia following heart-lung transplantation. Immunohematology 1992;8:38–40.

    PubMed  CAS  Google Scholar 

  85. Knoop C, Andrien M, Antoine M, Lambermont M, Yernault JC, Dupont E, Goldman M, Estenne M. Severe hemolysis due to a donor anti-D antibody after heart-lung transplantation. Association with lung and blood chimerism. Am Rev Respir Dis 1993;148:504–506.

    PubMed  CAS  Google Scholar 

  86. Lasky LC, Warkentin PI, Kersey JH, Ramsay NKC, McGlare PB, McCullough J. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Transfusion 1983;23:277–285.

    Article  PubMed  CAS  Google Scholar 

  87. Bradley R, Triulzi DJ, Starzl TE. Donor derived red cell antibodies in liver transplant recipients treated with FK-506 (abstract). Transfusion 1993;33(Suppl):S163.

    Google Scholar 

  88. Triulzi DJ, Jochum EE. Red cell compatibility testing in baboon xenotransplantation. Transfusion 1995;35:756–759.

    Article  PubMed  CAS  Google Scholar 

  89. Triulzi DJ, Jochum EA, Marino IR, Starzl TE. Heteroagglutinins and their significance in baboon hepatic xenotransplantation. Transplantation 1995;60:127–131.

    PubMed  CAS  Google Scholar 

  90. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579–1582.

    Article  PubMed  CAS  Google Scholar 

  91. Fontes P, Rao AS, Demetris AJ, Zeevi A, Trucco M, Carroll P, Rybka W, Rudert WA, Ricordi C, Dodson F, Shapiro R, Tzakis A, Todo S, Abu-Elmagd K, Jordan M, Fung JJ, Starzl TE. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 1994;344:151–155.

    Article  PubMed  CAS  Google Scholar 

  92. Papadopoulos EB, Ladanyi M, Emmanuel D. Infusions of donor leukocytes to treat Epstein-Barr virus associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994;330:1185–1191.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Darrell J. Triulzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. New York Blood Center, NY, USA

    Marion E. Reid PhD

  2. American Red Cross Blood Services, Philadelphia, PA, USA

    Sandra J. Nance MS, MT(ASCP)SBB

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Triulzi, D.J. (1998). Transfusion Support in Solid-Organ Transplantation. In: Reid, M.E., Nance, S.J. (eds) Red Cell Transfusion. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1798-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1798-5_7

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-7288-5

  • Online ISBN: 978-1-4612-1798-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation